28th Jul 2021 18:10
Ap24
AMENDMENT
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN ACLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 28 June 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
1,169,468 | 10.7100 GBP | 10.6500 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
532,244 | 10.7030 GBP | 10.6500 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a Long Position
Opening a Short Position
| 14,215 73 1,871
3,566 3,687 6,500 119,252 22,939 212,379 30,000
2,443 8,210 418 600
21,386 558,000 262
12,364 1,787 40,444 1,908 2,312 359 17,479 938 13,963 1,599
53,958 9,603 18,498 150,000 11,094 300,000 | 10.6659 GBP 10.6935 GBP 10.6966 GBP
10.6598 GBP 10.6623 GBP 10.6729 GBP 10.6751 GBP 10.6788 GBP 10.7010 GBP 10.6947 GBP
10.6598 GBP 10.6699 GBP 10.6705 GBP 10.6899 GBP
10.6609 GBP 10.6680 GBP 10.6804 GBP
10.6594 GBP 10.6595 GBP 10.6600 GBP 10.6635 GBP 10.6664 GBP 10.6683 GBP 10.6752 GBP 10.6755 GBP 10.6792 GBP 10.6847 GBP
10.6600 GBP 10.6601 GBP 10.6664 GBP 10.6954 GBP 10.7006 GBP 10.7054 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.
Date of disclosure | 28 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L